130 related articles for article (PubMed ID: 26475383)
1. Association of polymorphisms in PRKCI gene and risk of prostate cancer in a sample of Iranian Population.
Hashemi M; Shahkar G; Simforoosh N; Basiri A; Ziaee SA; Narouie B; Taheri M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):16-21. PubMed ID: 26475383
[TBL] [Abstract][Full Text] [Related]
2. Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population.
Li Q; Gu C; Zhu Y; Wang M; Yang Y; Wang J; Jin L; Zhu ML; Shi TY; He J; Ye D; Wei Q
Mol Carcinog; 2015 Aug; 54(8):632-41. PubMed ID: 24510606
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population.
Sattarifard H; Hashemi M; Hassanzarei S; Basiri A; Narouie B; Ghavami S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(1):1-11. PubMed ID: 30587086
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population.
Narouie B; Ziaee SAM; Basiri A; Hashemi M
Gene; 2017 Aug; 626():354-357. PubMed ID: 28578017
[TBL] [Abstract][Full Text] [Related]
5. ERBB4 gene polymorphisms and the risk of prostate cancer in a sample of Iranian Population.
Hashemi M; Moradi N; Rezaei M; Sanaei S; Ziaee SA; Narouie B; Sotoudeh M; Bahari G; Ghavami S
Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(10):43-8. PubMed ID: 27609473
[TBL] [Abstract][Full Text] [Related]
6. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.
Bahari G; Hashemi M; Naderi M; Taheri M
Tumour Biol; 2016 Jul; 37(7):9579-86. PubMed ID: 26790447
[TBL] [Abstract][Full Text] [Related]
7. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M
Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population.
Branković A; Brajušković G; Nikolić Z; Vukotić V; Cerović S; Savić-Pavićević D; Romac S
Int J Exp Pathol; 2013 Dec; 94(6):355-61. PubMed ID: 23998439
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Hüsing A; Stein A; Dostal L; Boeing H; Pischon T; Tjønneland A; Roswall N; Overvad K; Østergaard JN; Rodríguez L; Sala N; Sánchez MJ; Larrañaga N; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Allen NE; Lagiou P; Trichopoulou A; Trichopoulos D; Palli D; Sieri S; Tumino R; Sacerdote C; van Kranen H; Bueno-de-Mesquita HB; Hallmans G; Johansson M; Romieu I; Jenab M; Cox DG; Siddiq A; Riboli E; Canzian F; Kaaks R
PLoS One; 2011 Feb; 6(2):e16914. PubMed ID: 21373201
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.
Zou YF; Wang F; Feng XL; Tian YH; Tao JH; Pan FM; Huang F
Eur J Cancer; 2011 May; 47(7):1072-9. PubMed ID: 21211963
[TBL] [Abstract][Full Text] [Related]
11. Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population.
Hashemi M; Moradi N; Ziaee SA; Narouie B; Soltani MH; Rezaei M; Shahkar G; Taheri M
J Adv Res; 2016 May; 7(3):491-8. PubMed ID: 27222754
[TBL] [Abstract][Full Text] [Related]
12. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
13. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.
Singal R; Das PM; Manoharan M; Reis IM; Schlesselman JJ
Oncol Rep; 2005 Aug; 14(2):569-73. PubMed ID: 16012746
[TBL] [Abstract][Full Text] [Related]
15. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
Ding WH; Ren KW; Yue C; Zou JG; Zuo L; Zhang LF; Bai Y; Okada A; Yasui T; Mi YY
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413614
[TBL] [Abstract][Full Text] [Related]
16. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population.
Hashemi M; Sanaei S; Mashhadi MA; Hashemi SM; Taheri M; Ghavami S
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):69-73. PubMed ID: 26718432
[TBL] [Abstract][Full Text] [Related]
17. 4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population.
Hashemi M; Bahari G; Sarhadi S; Eskandari E; Narouie B; Taheri M; Ghavami S
J Cell Biochem; 2018 Mar; 119(3):2627-2635. PubMed ID: 29023981
[TBL] [Abstract][Full Text] [Related]
18. Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.
Zhang M; Wang Y; Wang C; You Z; Chen S; Kong Q; Xu B; Liu C; Chen M
Medicine (Baltimore); 2019 Dec; 98(52):e18523. PubMed ID: 31876746
[TBL] [Abstract][Full Text] [Related]
19. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
[TBL] [Abstract][Full Text] [Related]
20. Association between tumor necrosis factor-alpha gene rs1800629 (-308G/A) and rs361525 (-238G > A) polymorphisms and prostate cancer risk in an Iranian cohort.
Alidoost S; Habibi M; Noormohammadi Z; Hosseini J; Azargashb E; Pouresmaeili F
Hum Antibodies; 2020; 28(1):65-74. PubMed ID: 31594215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]